Yangzhou No.1 People's Hospital Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT02481193
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Yangzhou No. 1 Peoples' Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

cisatracurium (nimbex) (2 trials)

Drugs in Phase 2 Trials (2)

Filgrastim (neupogen) (1 trial)

sargramostim (leukine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fasciculation (Phase 3)

Myalgia (Phase 3)

Neutropenia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3